Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1368789 | Bioorganic & Medicinal Chemistry Letters | 2016 | 5 Pages |
Abstract
The paper will describe the synthesis and SAR studies that led to the discovery of benzamide (reverse amide) as potent and selective human β3-adrenergic receptor agonist. Based on conformationally restricted pyrrolidine scaffold we discovered earlier, pyrrolidine benzoic acid intermediate 22 was synthesized. From library synthesis and further optimization efforts, several structurally diverse reverse amides such as 24c and 24i were found to have excellent human β3-adrenergic potency and good selectivity over the β1 and β2 receptors. In addition to human β1, β2, β3 and hERG data, PK of selected compounds will be described.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Cheng Zhu, Nam F. Kar, Bing Li, Melissa Costa, Karen H. Dingley, Jerry Di Salvo, Sookhee N. Ha, Amanda L. Hurley, Xiaofang Li, Randy R. Miller, Gino M. Salituro, Mary Struthers, Ann E. Weber, Jeffrey J. Hale, Scott D. Edmondson,